Abstract Chronic ataxia is a relatively common symptom in children. There are numerous causes of chronic ataxia, making it difficult to derive a diagnosis in a timely manner. We hypothesized that the efficiency of the diagnostic process can be improved with systematic analysis of clinical features in pediatric patients with chronic ataxia. Our aim was to improve the efficiency of the diagnostic process in pediatric patients with chronic ataxia. A cohort of 184 patients, aged 0-16 years with chronic ataxia who received medical care at Winnipeg Children's Hospital during 1991-2008, was ascertained retrospectively from several hospital databases. Clinical details were extracted from hospital charts. The data were compared among the more common diseases using univariate analysis to identify pertinent clinical features that could potentially improve the efficiency of the diagnostic process. Latent class analysis was then conducted to detect unique patterns of clinical features and to determine whether these patterns could be associated with chronic ataxia diagnoses. Two models each with three classes were chosen based on statistical criteria and clinical knowledge for best fit. Each class represented a specific pattern of presenting symptoms or other clinical features. The three classes corresponded to a plausible and shorter list of possible diagnoses. For example, developmental delay and hypotonia correlated best with Angelman syndrome. Specific patterns of presenting symptoms or other clinical features can potentially aid in the initial assessment and diagnosis of pediatric patients with chronic ataxia. This will likely improve the efficiency of the diagnostic process.
Introduction
Chronic ataxia, defined as persistent, episodic, or intermittent ataxia longer than 2 months in duration [1, 2] , is a relatively common presentation in pediatrics [1] [2] [3] , with an annual crude incidence rate of 3.2 per 100,000 children <17 years of age in Manitoba [1] . The mental and physical disabilities encountered by these children and their families impose a significant financial burden on them and on the health-care system [4] .
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Numerous diseases are associated with chronic ataxia, making it difficult to derive a diagnosis early in the course of the disease, because ataxia may be the sole symptom [2, 5] , at least initially. In addition, there is a considerable overlap of clinical features among the various diseases that cause chronic ataxia, which complicates the clinical assessment [5] . Therefore, the cost of assessing patients with chronic ataxia is considerable [4] , because of the need for multiple clinic follow-up visits and extensive investigations.
There are several published reviews on the assessment of pediatric patients with ataxia based on small case series, personal experience [2, 5, 6] , and neuroimaging findings in the posterior fossa [7, 8] . Many studies have concentrated solely on the assessment of inherited ataxia [2, 9] or specific diseases with ataxia [6, 10] . Recently, the value of neuroimaging in the investigation of patients with chronic ataxia and the spectrum of neuroimaging findings in our patients have been published [11] .
We did not find any studies that systematically investigated the clinical features of a large cohort of children with diverse causes of chronic ataxia. Furthermore, clinical studies aiming to improve the diagnostic process of pediatric patients with chronic ataxia are lacking.
In this clinical study, we hypothesized that the efficiency of the diagnostic process can be improved with systematic analysis of clinical features in a large cohort of pediatric patients with chronic ataxia. The aims of our study were to (1) describe and compare the clinical findings in children and adolescents with chronic ataxia according to their diagnoses, (2) identify pertinent clinical features that may be associated with specific diseases, and (3) determine if there are specific patterns of presenting symptoms and other clinical features that could improve the efficiency of the diagnostic process.
Method
A cohort of 184 pediatric patients who received medical care at Winnipeg Children's Hospital during 1991-2008 was established retrospectively from several hospital databases [1] . All selected children had chronic ataxia (>2 months or episodic/intermittent) and were <17 years at presentation. Ethics approval was granted by the Research Ethics Board of the University of Manitoba. Patients were excluded if their ataxia was caused by primary brain tumor or by disorders solely involving the vestibular or peripheral nervous systems. Further details on the methodology have been published on this cohort [1, 12] . Clinical variables were extracted from the patients' hospital charts including presenting symptoms, other symptoms, past medical history, family history, and physical exam findings.
Patients were investigated extensively. Almost all patients (N = 177) had neuroimaging (mostly MRI and rarely CT) [11] . Routine tests (including total blood count, ESR, electrolytes, glucose, calcium, phosphorus, magnesium, albumin, creatinine kinase, liver, and thyroid function tests), alpha fetoprotein, immunoglobulins, autoimmune (including ANA, ANCA), metabolic (including uric acid, lactate, ammonia, amino acids, organic acids, total and free carnitine, acylcarnitine, vitamins E and B 12 , lysosomal enzymes, very long chain fatty acids, CSF neurotransmitters), and genetic (including karyotype, FISH, calcium channel mutations, mutations in selected spinocerebellar ataxia genes, chromosomal breakage studies, specific genetic testing for Angelman syndrome and Rett syndrome) on blood, urine, and CSF were performed in a stepwise manner. Nerve conduction studies, electromyogram, EEG and skin and muscle biopsies were also done in selected patients.
The Statistical Analysis System (SAS) version 9.3 (SAS Institute, Cary, NC) was used for the analysis of the data including calculation of frequencies of the clinical features. Where data displayed normal distribution, mean and standard deviation were reported. For skewed data, median and range were reported.
Univariate Analysis Univariate analysis was conducted among nine of the more common diseases (109 patients) due to statistical limitations of the data, using Pearson's chi-square test for categorical variables and Kruskal-Wallis test for continuous variables. Results were considered significant when p was < 0.05. The purposes of the univariate analysis were to describe the frequency of each of the clinical features among the diseases and to investigate whether the frequencies differed significantly among them. Due to the large number of diagnoses and rare clinical features, the Pearson's chi-square and Kruskal-Wallis tests should be considered preliminary and exploratory.
Latent Class Analysis Latent class analysis (LCA) is a statistical method for detecting multiple sets of patterns among responses to categorical items, questions, or features, which are used to infer the existence of homogeneous subgroups and provide insights into their nature [13, 14] . It attempts to assign mutually exclusive class membership (or subgroups) based on latent patterns among observed variables [15] . Membership in a class is considered latent or hidden because membership in it cannot be directly observed. This is akin to various clinical features being linked to a diagnosis that is unknown on the initial clinic visits.
The goal of the LCA was to find patterns of clinical features among children with chronic ataxia. Such patterns may be useful to clinicians during the initial clinical assessments and may offer insights for better understanding the etiology. We focused on (1) presenting symptoms and (2) other clinical features in all 184 patients. Each presenting symptom and clinical feature was considered to be a useful class descriptor if its prevalence differed substantially among classes, especially if it was also homogeneous within a given class. The latent classes were then compared to the diagnoses by using the likeliest predictor class for each subject. The models were performed using PROC LCA, an auxiliary procedure for SAS, which can be downloaded from Penn State University [15] .
LCA of the Presenting Symptoms Each of the selected presenting symptoms had to be present in at least 10 patients for it to be included in the LCA. All presenting symptoms were dichotomous variables (i.e., present/absent).
LCA of the Other Clinical Features Given the constraints of this retrospective study with missing or incomplete data, significant statistical results found in the univariate analysis and clinical knowledge of the diseases investigated were both used to select important clinical features for the LCA. The second LCA was performed on 14 other clinical features. Seven of 14 clinical features were dichotomous variables. The other seven were converted to categorical variables (i.e., divided into three or more categories).
LCA Models Exploratory LCA models with two, three, and four class membership were first investigated. Larger models were inestimable given sample size constraints. The LCA models for best fit were chosen based on statistical criteria in combination with clinical knowledge about the diseases investigated in this study. Statistical criteria were based on the lowest Akaike information criteria (AIC), Bayesian information criteria (BIC), and G 2 values [15] . Fourteen disease categories were then associated with each class of the chosen models. Each disease had at least five patients. The uncommon diagnoses (i.e., present in <five patients) were grouped under "other" (n = 50).
Results
The mean age (SD) at the end of the study on the 184 patients (M = 92) was 15 years Univariate Analysis Univariate analysis on 55 variables revealed 33 statistically significant clinical features and one important trend (Supplementary Table 1 ). Table 1 shows pertinent clinical features among nine of the more common diagnoses that were statistically significant.
Other Important Findings Dyskinesia in ataxia telangiectasia was present in 7 of 10 patients where it was recorded (p = 0.004); however, 49 % of the data in the whole cohort were missing. Joint position sense in Friedreich ataxia was decreased or absent in all seven patients with the disease (p = 0.001); however, 69 % of the data were missing. In addition, nystagmus in episodic ataxia was reported in five of seven patients with the disease (p = 0.06), representing an important clinical trend.
LCA Models LCA models with two, three, and four class membership were first investigated. For the LCA of the presenting symptoms, the three-class model was chosen because it had a lowest AIC value (Supplementary Table 2 ) and was the best clinical fit. For the LCA of other clinical features, the AIC, BIC, and G 2 values suggested two-or four-class models. However, these models were not clinically useful; in the twoclass model, most of the data clustered around one of the two classes, while in the four-class model, the probabilities among the classes for several of the clinical features were similar and did not segregate the classes into more distinct clinical subgroups. Therefore, a three-class model was chosen because it was more plausible, useful, relevant, and the best clinical fit (Tables 2 and 3 ). The tables show the probabilities for each presenting symptom and other clinical feature belonging to each class and their association with 14 disease categories.
The variables and associated diagnoses in each class below are listed in order of highest to lowest probabilities. (Table 2) Class 1-"Gait Abnormality Subgroup"
LCA of the Presenting Symptoms
Patients in class 1 commonly had gait abnormality. Seizures, tremor, speech delay, gross motor delay, and head titubation were less frequent. The most common diagnoses associated were Friedreich ataxia, ataxia telangiectasia, hypoxic ischemic encephalopathy after birth (HIE), mitochondrial disease, intractable epilepsy syndrome, intermittent ataxia not yet diagnosed (NYD), and neuronal ceroid lipofuscinosis (NCL). Based on our sample, the estimated prevalence of this class in the general chronic ataxia population is 43.1 %.
Class 2-"Global Developmental Delay Subgroup"
Patients in class 2 had global developmental delay almost universally. Hypotonia and seizures occurred relatively commonly. The most common diagnoses associated were Angelman syndrome, nonprogressive ataxia NYD, Joubert syndrome and related disorders (JS), and neuronal migration disorders (NMD). Based on our sample, the estimated prevalence of this class in the general chronic ataxia population is 38 %. Numbers in italics indicate the highest probabilities for presenting symptoms (A) and associated diagnoses (B), and the class they were assigned to
NYD not yet diagnosed Patients in class 3 had gait abnormality commonly. Visual abnormalities, headache, dizziness, weakness, and dysarthria were less common symptoms. The most common diagnoses associated were episodic ataxia, posterior fossa ischemic stroke, and intermittent ataxia NYD. Based on our sample, the estimated prevalence of this class in the general chronic ataxia population is 18.9 %. (Table 3) For clinical features with more than two responses, e.g., speech abnormalities, lower limb reflexes, and age of ataxia onset, there was variation in the probability of each response within the same class .
LCA of the Other Clinical Features
Class 1-"Young Age of Ataxia Onset, Developmental Delay, and Dysarthria Subgroup"
Patients in class 1 commonly had slurred/scanning speech, global developmental delay, ataxia onset under 6 years of age, and head titubation. Other less common features were decreased lower limb reflexes, sleep difficulties, normal speech, consanguineous parents, and generalized seizures. The most common diagnoses associated were ataxia telangiectasia, intermittent ataxia NYD, posterior fossa ischemic stroke, and nonprogressive ataxia NYD. Based on our sample, the estimated prevalence of this class in the general chronic ataxia population is 35.7 %. seizures, head titubation, and developmental regression were other less common features. The most common diagnoses associated were NCL, Angelman syndrome, NMD, intractable epilepsy syndrome, JS, HIE, and mitochondrial disease. Based on our sample, the estimated prevalence of this class in the general chronic ataxia population is 48 %.
Class 3-"Older Age of Ataxia Onset and Normal Development Subgroup"
Patients in class 3 had no seizures, ataxia onset after 6 years of age, symptom onset after 6 years of age, normal development, slurred or scanning speech, and a family history of ataxia. Symptoms that may improve over time, decreased lower limb reflexes, decreased strength, normal speech, and abnormal fundus examination occurred less commonly. The most common diagnoses associated were episodic ataxia and Friedreich ataxia. Based on our sample, the estimated prevalence of this class in the general chronic ataxia population is 16.3 %. Table 4 shows a summary of both LCA and their associated diagnoses.
Discussion
The clinical features of many diseases that cause chronic ataxia in pediatric patients are well established [2, 3, 5, 6, 9, 10] . However, there is a considerable clinical overlap among disorders associated with chronic ataxia with challenges in establishing the diagnosis on the initial clinic visits [2] . Although neuroimaging can be helpful in pediatric patients with persisting or recurrent ataxia [7, 8] , the diagnosis is more challenging when neuroimaging is normal or shows nonspecific abnormalities. Choosing Wisely Canada is part of an international campaign to reduce unnecessary tests, treatments, and procedures on patients. It encourages medical professionals to question the medical culture that "more is better" [16, 17] . It aims to reduce the harm, false positives, stress, and resources associated with unnecessary test, procedures, and treatments. Our study aims were in accordance with Choosing Wisely principles, namely to identify specific Numbers in italics indicate the highest probabilities for the other clinical features (A) and associated diagnoses (B), and the classes they were assigned to
NYD not yet diagnosed patterns of clinical features that can potentially reduce the number of tests and procedures, and improve the efficiency of the diagnostic process in pediatric patients with chronic ataxia. Several clinical features were found to be statistically significant on univariate analysis. These features were consistent with the literature reports on the diseases described [10, [18] [19] [20] [21] [22] [23] [24] [25] . Due to statistical constraints of the data, only some of these variables were investigated using LCA.
To the best of our knowledge, this study is the first to use LCA to investigate clinical features in pediatric chronic ataxia. Since patients present at different stages of their disease for assessment, the LCA was performed independently on the presenting symptoms and also on other clinical features, because some of the clinical features may not be present on the initial assessment. We identified three distinct latent classes.
LCA of the Presenting Symptoms
Class 1 "gait abnormality subgroup" describes children who commonly present with abnormalities in gait. Seizures, tremor, and speech delay are less common. Seizures, if present, will help distinguish this class from class 3 patients. Class 3 is more likely to present with visual disturbances, headaches, or dizziness.
The two most common diagnoses in class 1 are Friedreich ataxia and ataxia telangiectasia. Both of these disorders have genetic tests available [2, 10, 19] . If blood alpha fetoprotein level is elevated, then genetic testing for ataxia telangiectasia should be pursued first [5] . Other diseases associated with class 1 include mitochondrial disease and NCL, which can be specifically tested using biochemical and genetic tests, brain MRI/MRS, and if necessary muscle biopsy [2, 20, 21, 25] . Patients with class 3 pattern can be investigated for episodic ataxia by specific genetic testing [24] . Class 2 "global developmental delay subgroup" is distinct from classes 1 and 3. Children in this class very frequently have global developmental delay and present with floppiness and seizures. If a patient fits class 2 pattern, Angelman syndrome and NMD should be considered. A brain MRI is essential in diagnosing NMD [23] , while genetic testing is available for Angelman syndrome in which a normal brain MRI is typical [18] . Joubert syndrome and related disorders have specific brain MRI features (molar tooth sign) that are diagnostic [26] .
Not all presenting symptoms were useful for class discrimination and description. Developmental regression, gait abnormality, and gross motor delay in particular showed similar prevalence among the three classes and, hence, were unassociated with class membership.
Inquiring about developmental regression is an essential part of the clinical assessment; however, in the LCA model, it infrequently featured in all three classes. It may not be an apparent or obvious feature in the early stages of neurodegenerative disorders.
LCA of the Other Clinical Features
Classes 1 and 2 patients present more commonly at a younger age. Developmental delay and speech difficulties occur almost universally. However, some patients in class 1 have decreased lower limb reflexes, while many patients in class 2 have brisk lower limb reflexes. Furthermore, no/limited speech content is common in class 2 patients, while scanning/slurred speech is common in class 1 patients. If dysmorphic features or developmental regression is observed, then diseases associated with class 2 should be considered.
Patients in class 3 are relatively easily differentiated from patients in classes 1 and 2 based on their later age of presentation and normal development. Patients in this class do not have seizures and may have a family history of ataxia. Further tests to confirm specific diagnoses within this class are available [10, 24] .
Not all clinical features were very useful for discriminating class characteristics. For example, consanguinity had a relatively similar prevalence among all three classes, meaning it was not highly predictive of class membership and therefore cannot be a descriptor of them. The same was true of decreased muscle strength and symptom change.
The three classes of presenting symptoms and other clinical features are each associated with diseases that are segregated unevenly among the classes with some exceptions (Table 4) . For example, both Friedreich ataxia and ataxia telangiectasia are associated with class 1 of the presenting symptoms in the LCA, while Friedreich ataxia is associated with class 3 in the LCA of other clinical features with ataxia telangiectasia in class 1 of other clinical features. This will further narrow the diagnostic possibilities.
Limitations of this retrospective study are misclassification of clinical features, missing data, or incomplete information. Therefore, not all of the presenting symptoms or other clinical features could be included in the univariate analysis or LCA. Overall sample size constraints further limited the number of variables in the LCA models. In addition, important clinical features and exam findings may not have been present at the time of patient presentation to the clinic, and the low number of responses for some variables may have reduced the power of the study to detect important differences in the results. Furthermore, it was not feasible for patients with rare diseases (i.e., N = 1-2) to be investigated using LCA. Some diseases with chronic ataxia were not represented in our cohort; therefore, the cohort may not be representative of the general population outside our province. For some disease categories with few subtypes, for example NCL, mitochondrial diseases, and episodic ataxia, we had to lump patients with different disease subtypes into one disease category in order to facilitate statistical analyses and modeling. The regional genetic makeup of our patients may influence the subtypes lumped, potentially limiting the generalization of our study findings. Lastly, nonprogressive cerebellar ataxia NYD, intermittent ataxia NYD, and other rare disorders that were combined in the analyses did not always segregate clearly into specific classes. This is expected, as they are composed of a heterogeneous group of disorders.
Conclusions
LCA can be helpful in the assessment of patients with chronic ataxia, where the underlying etiology is usually elusive, especially initially. There was an association among the three subgroups of presenting symptoms and other clinical features, with several of the more common diseases that cause chronic ataxia. The LCA subgroups reduced the list of diagnostic possibilities, which can potentially decrease the time to diagnosis, reduce the number of medical investigations, and decrease the financial costs on the health-care system. These objectives are consistent with the goals of Choosing Wisely [16, 17] .
A prospective evaluation of our LCA results to confirm/ refine our clinical subgroups will be important in future studies. In addition, investigating the contribution of neuroimaging in conjunction with our LCA results in the diagnosis of pediatric patients with chronic ataxia should be undertaken to improve the efficiency of the diagnostic process further.
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